Table 4.

Baseline and 12-Month Summative Metabolic Risk Scores With Psychiatric Medications^a

	PCS Group (n = 60)		NCS Group (n = 60)
Summative Metabolic Risk Scores	Mean (SD)	Median (range)	Mean (SD)	Median (range)	t Test P Value
Baselineb	2.53 (1.59)	2 (1–9)	2.63 (1.46)	3 (1–7)	.72
12 Monthsc	2.40 (1.56)	2 (0–7)	2.59 (1.41)	3 (0–6)	.5346

^aPsychiatric medication metabolic risk scores (lowest −1, 0, 1, 2, 3 highest). Typical antipsychotics: haloperidol, fluphenazine, trifluoperazine, perphenazine, prochlorperazine, loxapine, molindone = 1; chlorpromazine, thioridazine = 2. Atypical antipsychotics: clozapine, olanzapine, quetiapine = 3; risperidone, iloperidone, paliperidone, asenapine = 2; lurasidone, ziprasidone, aripiprazole = 1. Serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors = 1, buspirone = 1; paroxetine, mirtazapine, vilazodone = 2; lithium/divalproex = 2; bupropion = 0; carbamazepine/oxcarbazapine, gabapentin, pregabalin, lamotrigine = 0; topiramate/zonisamide = −1. Stimulants = −1.

^bPCS group: n = 60; NCS group: n = 60.

^cPCS group: n = 45; NCS group: n = 49.

Abbreviations: NCS = no pharmacist comprehensive medication management services control subject group, PCS = pharmacist comprehensive medication management services subject group.